OTC labeling meeting postponed
This article was originally published in The Tan Sheet
Executive Summary
FDA/industry working group meeting scheduled for Nov. 1 postponed to allow more time to review product relabeling sample submissions. Due to other commitments, FDA "personnel will not permit a shortened review time of the materials," the agency says. The first available date to reschedule the OTC labeling meeting is Nov. 23 from 10 a.m. to noon
You may also be interested in...
Trade Dress, Multiple Columns Need Quick Resolution - CHPA
Issues of columns and trade dress "have lingered too long and a response from FDA is urgently needed," the Consumer Healthcare Products Association asserts in an Oct. 22 letter to the agency.
Trade Dress, Multiple Columns Need Quick Resolution - CHPA
Issues of columns and trade dress "have lingered too long and a response from FDA is urgently needed," the Consumer Healthcare Products Association asserts in an Oct. 22 letter to the agency.
Trade Dress, Multiple Columns Need Quick Resolution - CHPA
Issues of columns and trade dress "have lingered too long and a response from FDA is urgently needed," the Consumer Healthcare Products Association asserts in an Oct. 22 letter to the agency.